➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Last Updated: September 17, 2021

DrugPatentWatch Database Preview

Investigational Drug Information for BGG492

Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug BGG492?

BGG492 is an investigational drug.

There have been 10 clinical trials for BGG492. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2009.

The most common disease conditions in clinical trials are Seizures, Migraine Disorders, and Epilepsy. The leading clinical trial sponsors are Novartis Pharmaceuticals, Novartis, and [disabled in preview].

Recent Clinical Trials for BGG492
Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Due to Multiple SclerosisNovartis PharmaceuticalsPhase 2
A Randomized,Double Blind, Placebo Controlled Study to Assess Efficacy,Safety and Tolerability of BGG492 in Migraine PreventionNovartis PharmaceuticalsPhase 2
Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492Novartis PharmaceuticalsPhase 2

See all BGG492 clinical trials

Clinical Trial Summary for BGG492

Top disease conditions for BGG492
Top clinical trial sponsors for BGG492

See all BGG492 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.